S&P 500   4,305.20
DOW   34,152.01
QQQ   332.28
3 Stocks Set to Lead the Nasdaq Bull Market
US Dollar Replaced By "Biden Bucks"? (Ad)
3 Blowout Earnings Reports That Could Mark Turning Points
Companies facing 1st tax on stock buybacks in Biden bill
Will CrowdStrike Extend Its Streak Of Topping Earnings Views?
US Dollar Replaced By "Biden Bucks"? (Ad)
Is Ford About To Crush Workhorse Group? 
Home Depot Results Point To Sluggish 2nd Half
Skyworks Solutions Is Worth A Look At These Prices 
The Day of Financial Reckoning Is Near (Ad)
S&P 500   4,305.20
DOW   34,152.01
QQQ   332.28
3 Stocks Set to Lead the Nasdaq Bull Market
US Dollar Replaced By "Biden Bucks"? (Ad)
3 Blowout Earnings Reports That Could Mark Turning Points
Companies facing 1st tax on stock buybacks in Biden bill
Will CrowdStrike Extend Its Streak Of Topping Earnings Views?
US Dollar Replaced By "Biden Bucks"? (Ad)
Is Ford About To Crush Workhorse Group? 
Home Depot Results Point To Sluggish 2nd Half
Skyworks Solutions Is Worth A Look At These Prices 
The Day of Financial Reckoning Is Near (Ad)
S&P 500   4,305.20
DOW   34,152.01
QQQ   332.28
3 Stocks Set to Lead the Nasdaq Bull Market
US Dollar Replaced By "Biden Bucks"? (Ad)
3 Blowout Earnings Reports That Could Mark Turning Points
Companies facing 1st tax on stock buybacks in Biden bill
Will CrowdStrike Extend Its Streak Of Topping Earnings Views?
US Dollar Replaced By "Biden Bucks"? (Ad)
Is Ford About To Crush Workhorse Group? 
Home Depot Results Point To Sluggish 2nd Half
Skyworks Solutions Is Worth A Look At These Prices 
The Day of Financial Reckoning Is Near (Ad)
S&P 500   4,305.20
DOW   34,152.01
QQQ   332.28
3 Stocks Set to Lead the Nasdaq Bull Market
US Dollar Replaced By "Biden Bucks"? (Ad)
3 Blowout Earnings Reports That Could Mark Turning Points
Companies facing 1st tax on stock buybacks in Biden bill
Will CrowdStrike Extend Its Streak Of Topping Earnings Views?
US Dollar Replaced By "Biden Bucks"? (Ad)
Is Ford About To Crush Workhorse Group? 
Home Depot Results Point To Sluggish 2nd Half
Skyworks Solutions Is Worth A Look At These Prices 
The Day of Financial Reckoning Is Near (Ad)
OTCMKTS:ESALY

Eisai - ESALY Stock Forecast, Price & News

$46.45
-0.11 (-0.24%)
(As of 08/16/2022 12:00 AM ET)
Add
Compare
Today's Range
$46.20
$46.45
50-Day Range
$37.90
$46.56
52-Week Range
$36.88
$85.10
Volume
9,849 shs
Average Volume
24,285 shs
Market Capitalization
$13.32 billion
P/E Ratio
51.04
Dividend Yield
2.28%
Price Target
N/A
ESALY stock logo

About Eisai (OTCMKTS:ESALY) Stock

Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.

Receive ESALY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eisai and its competitors with MarketBeat's FREE daily newsletter.

ESALY Stock News Headlines

Eisai Co., Ltd. (4523)
Eisai is about to announce its earnings — here's what to expect
Eisai Co (OTC:ESALY), Short Interest Report
Bear of the Day: Biogen (BIIB)
See More Headlines
Receive ESALY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eisai and its competitors with MarketBeat's FREE daily newsletter.

ESALY Company Calendar

Last Earnings
8/04/2021
Today
8/16/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Private households
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ESALY
Employees
11,322
Year Founded
N/A

Profitability

Net Income
$426.79 million
Pretax Margin
7.20%

Debt

Sales & Book Value

Annual Sales
$6.74 billion
Cash Flow
$2.71 per share
Book Value
$23.94 per share

Miscellaneous

Free Float
N/A
Market Cap
$13.32 billion
Optionable
Not Optionable
Beta
0.42

Key Executives

  • Mr. Haruo Naito (Age 75)
    CEO, Representative Corp. Officer & Director
    Comp: $877.62k
  • Mr. Gary Hendler (Age 56)
    Sr. VP & Pres of EMEA Region
    Comp: $1.04M
  • Dr. Lynn D. Kramer FAAN (Age 72)
    M.D., VP & Chief Clinical Officer - Alzheimer's Disease and Brain Health
    Comp: $892.62k
  • Ms. Yanhui Feng (Age 50)
    Sr. VP
    Comp: $825.11k
  • Dr. Nadeem Sarwar Ph.D.
    Pres
  • Mr. Tatsuyuki Yasuno (Age 54)
    Sr. VP, CFO & Chief IR Officer
  • Mr. Kenta Takahashi (Age 63)
    Exec. VP, Gen. Counsel & Intellectual Property Internal Audit
  • Mr. Yosuke Akita (Age 57)
    VP, Chief Compliance Officer & Chief Information Security Officer
  • Ms. Sayoko Sasaki (Age 54)
    VP of Corp. Communications & ESG
  • Mr. Teruyuki Masaka (Age 44)
    VP & Chief HR Officer













ESALY Stock - Frequently Asked Questions

Should I buy or sell Eisai stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Eisai in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ESALY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ESALY, but not buy additional shares or sell existing shares.
View ESALY analyst ratings
or view top-rated stocks.

How have ESALY shares performed in 2022?

Eisai's stock was trading at $56.82 on January 1st, 2022. Since then, ESALY shares have decreased by 18.3% and is now trading at $46.45.
View the best growth stocks for 2022 here
.

How were Eisai's earnings last quarter?

Eisai Co., Ltd. (OTCMKTS:ESALY) issued its quarterly earnings data on Wednesday, August, 4th. The company reported $1.34 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.09 by $0.25. The business had revenue of $1.82 billion for the quarter. Eisai had a net margin of 4.14% and a trailing twelve-month return on equity of 3.85%.

Is Eisai a good dividend stock?

Eisai (OTCMKTS:ESALY) pays an annual dividend of $1.06 per share and currently has a dividend yield of 2.28%. The dividend payout ratio is 116.48%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, ESALY will have a dividend payout ratio of 74.13% next year. This indicates that the company will be able to sustain or increase its dividend.

What guidance has Eisai issued on next quarter's earnings?

Eisai issued an update on its FY 2023 earnings guidance on Friday, June, 10th. The company provided EPS guidance of $1.37-$1.37 for the period. The company issued revenue guidance of $6.03 billion-$6.03 billion.

What is Eisai's stock symbol?

Eisai trades on the OTCMKTS under the ticker symbol "ESALY."

How do I buy shares of Eisai?

Shares of ESALY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Eisai's stock price today?

One share of ESALY stock can currently be purchased for approximately $46.45.

How much money does Eisai make?

Eisai (OTCMKTS:ESALY) has a market capitalization of $13.32 billion and generates $6.74 billion in revenue each year. The company earns $426.79 million in net income (profit) each year or $0.91 on an earnings per share basis.

How many employees does Eisai have?

The company employs 11,322 workers across the globe.

How can I contact Eisai?

Eisai's mailing address is 4-6-10 Koishikawa Bunkyo-ku, Tokyo M0, 112-8088. The official website for the company is www.eisai.co.jp. The company can be reached via phone at (133) 817-3700 or via fax at 813-3811-6032.

This page (OTCMKTS:ESALY) was last updated on 8/17/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.